| [1] |
Drummond K, Danesh NM, Arseneault S, et al. Association between endometriosis and risk of preeclampsia in women who conceived spontaneously: a systematic review and meta-analysis[J]. J Minim Invasive Gynecol，2023，30(2)：91-99.
|
| [2] |
Reismullerova L, Holoman K, Polackova-Borosova M, et al. Polycystic ovary syndrome－a risk factor of pre-eclampsia after in vitro fertilisation[J]. Bratisl Lek Listy，2015，116(5)：311-315.
|
| [3] |
Reckelhoff JF. Polycystic ovary syndrome: androgens and hypertension[J]. Hypertension，2007，49(6)：1220-1221.
|
| [4] |
Shao Y, Qiu J, Huang H, et al. Pre-pregnancy BMI, gestational weight gain and risk of preeclampsia: a birth cohort study in Lanzhou, China[J]. BMC Pregnancy Childbirth，2017，17(1)：1-8.
|
| [5] |
Gong X, Li J, Jiang Y, et al. Risk of preeclampsia by gestational weight gain in women with varied prepregnancy BMI: a retrospective cohort study[J]. Front Endocrinol (Lausanne)，2022，13：1-9.
|
| [6] |
Martin AS, Monsour M, Kawwass JF, et al. Risk of preeclampsia in pregnancies after assisted reproductive technology and ovarian stimulation[J]. Matern Child Health J，2016，20(10)：2050-2056.
|
| [7] |
Imudia AN, Awonuga AO, Doyle JO, et al. Peak serum estradiol level during controlled ovarian hyperstimulation is associated with increased risk of small for gestational age and preeclampsia in singleton pregnancies after in vitro fertilization[J]. Fertil Steril，2012，97(6)：1374-1379.
|
| [8] |
Erez O, Vardi IS, Hallak M, et al. Preeclampsia in twin gestations: association with IVF treatments, parity and maternal age[J]. J Matern Fetal Neonatal Med，2006，19(3)：141-146.
|
| [9] |
Sites CK, Wilson D, Bernson D, et al. Number of embryos transferred and diagnosis of preeclampsia[J]. Reprod Biol Endocrinol，2020，18(1)：1-7.
|
| [10] |
Severino AI, Póvoa AM. Frozen embryo transfer and preeclampsia risk[J]. J Gynecol Obstet Hum Reprod，2021，50(9)：1-5.
|
| [11] |
Weiss JL, Malone FD, Vidaver J, et al. Threatened abortion: a risk factor for poor pregnancy outcome, a population-based screening study[J]. Am J Obstet Gynecol，2004，190(3)：745-750.
|
| [12] |
Rotem R, Pariente G, Golevski M, et al. Association between hypertensive disorders of pregnancy and third stage of labor placental complications[J]. Pregnancy Hypertens，2018，13：166-170.
|
| [13] |
陈晨，赵先兰．体外受精-胚胎移植术后子痫前期患者临床特点分析[J/CD]. 中华产科急救电子杂志，2020，9(2)：106-110.
|
| [14] |
Calhoun KC, Barnhart KT, Elovitz MA, et al. Evaluating the association between assisted conception and the severity of preeclampsia[J]. ISRN Obstet Gynecol，2011，2011：1-5.
|
| [15] |
Lee KN, Song E, Lee S, et al. Association between in vitro fertilisation embryo transfer and placental pathology in women with preterm birth: a retrospective cohort study[J]. Reprod Fertil Dev，2022，34(18)：1107-1114.
|
| [16] |
郑晓芳，魏宋荃，黄真轩，等. 子痫前期合并胎儿生长受限的妊娠结局及胎盘病理改变的研究[J/OL]. 中华产科急救电子杂志，2023，12(2)：85-92.
|
| [17] |
Liu T, Gao R, Liu Y, et al. Hypertensive disorders of pregnancy and neonatal outcomes in twin vs. singleton pregnancies after assisted reproductive technology[J]. Front Pediatr，2022，10：1-12.
|
| [18] |
Dai F, Pan S, Lan Y, et al. Pregnancy outcomes and risk factors for preeclampsia in dichorionic twin pregnancies after in vitro fertilization: a five-year retrospective study[J]. BMC Pregnancy Childbirth，2022，22(1)：1-9.
|
| [19] |
Poon LC, Shennan A, Hyett JA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention[J]. Int J Gynaecol Obstet，2019，145 Suppl 1(Suppl 1)：1-33.
|
| [20] |
Zhong Y, Zhu F, Ding Y. Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis[J]. BMC Pregnancy Childbirth，2015，15：1-10.
|
| [21] |
Kalousová M, Muravská A, Zima T. Pregnancy-associated plasma protein A (PAPP-A) and preeclampsia[J]. Adv Clin Chem，2014，63：169-209.
|
| [22] |
Piskun A, Dmytro K, Honcharenko O, et al. Placental biomarkers: PP13, VEGF in diagnostics of early and late preeclampsia[J]. Wiad Lek，2022，75(12)：3041-3045.
|
| [23] |
Stepan H, Galindo A, Hund M, et al. Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction[J]. Ultrasound Obstet Gynecol，2023，61(2)：168-180.
|
| [24] |
Poon LC, Shennan A, Hyett JA, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention[J]. Int J Gynaecol Obstet，2019，145 Suppl 1(Suppl 1)：1-33.
|
| [25] |
焦婷婷. 体外授精——胚胎移植术后并发妊娠期高血压疾病预测模型[D]. 郑州：郑州大学，2020.
|
| [26] |
Zainul Rashid MR, Lim JF, Nawawi NH, et al. A pilot study to determine whether progestogen supplementation using dydrogesterone during the first trimester will reduce the incidence of gestational hypertension in primigravidae[J]. Gynecol Endocrinol，2014，30(3)：217-220.
|
| [27] |
Ali AB, Ahmad MF, Kwang NB, et al. Dydrogesterone support following assisted reproductive technique (ART) reduces the risk of pre-eclampsia[J]. Horm Mol Biol Clin Investig，2016，27(3)：93-96.
|
| [28] |
中华医学会妇产科学分会产科学组. 妊娠期及产褥期静脉血栓栓塞症预防和诊治专家共识[J].中华妇产科杂志，2021，56(4)：236-243.
|